NEURASIGNAL Trademark

Trademark Overview

On Thursday, November 30, 2023, a trademark application was filed for NEURASIGNAL with the United States Patent and Trademark Office. The USPTO has given the NEURASIGNAL trademark a serial number of 98292631. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, September 12, 2025. This trademark is owned by Neurasignal, Inc.. The NEURASIGNAL trademark is filed in the Advertising, Business and Retail Services category with the following description:

Compilation and systemization of medical data into computer databases; computerized physician and healthcare file management
neurasignal

General Information

Serial Number98292631
Word MarkNEURASIGNAL
Filing DateThursday, November 30, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, September 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements

Pseudo MarkNEURA SIGNAL
Goods and ServicesCompilation and systemization of medical data into computer databases; computerized physician and healthcare file management

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, November 30, 2023
Primary Code035
First Use Anywhere DateMonday, April 21, 2025
First Use In Commerce DateMonday, April 21, 2025

Trademark Owner History

Party NameNeurasignal, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024
Party NameNeurasignal, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024

Trademark Events

Event DateEvent Description
Thursday, November 30, 2023NEW APPLICATION ENTERED
Friday, February 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 22, 2024ASSIGNED TO EXAMINER
Tuesday, April 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 24, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 24, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, July 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 21, 2025USE AMENDMENT FILED
Monday, April 21, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, September 10, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 10, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 12, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 12, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

neurasignal physician healthcare file management computerized databases systemization medical data computer